Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Myxoedema coma

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Myxoedema coma is a high-mortality endocrine emergency. Call critical care and endocrinology immediately, manage ABCDE, give stress-dose glucocorticoid before thyroid hormone when adrenal insufficiency is not excluded, and use the current local emergency protocol with BNF-checked dosing.

Synopsis

Recognise decompensated severe hypothyroidism before coma is established, deliver endocrine-critical-care treatment in the correct sequence, and correct precipitating and metabolic threats safely.

  • The syndrome is severe physiological decompensation from hypothyroidism and does not require literal coma; altered cognition may range from slowing and delirium to unresponsiveness.
  • Think of the cluster: hypothermia, bradycardia, hypotension, hypoventilation or hypercapnia, hyponatraemia, hypoglycaemia, oedematous appearance and reduced consciousness.
  • Infection, cold exposure, myocardial infarction, stroke, sedatives or opioids, surgery and interruption of levothyroxine are important precipitants.
  • Obtain thyroid tests and cortisol promptly, but treatment must not be delayed for confirmatory results when the clinical syndrome is convincing.
  • Give parenteral hydrocortisone before thyroid hormone until clinically important adrenal insufficiency is excluded, because replacement can precipitate cortisol collapse.
  • After parenteral hydrocortisone, the current levothyroxine injection SmPC recommends an adult intravenous loading dose of 200–500 micrograms, never above 500 micrograms, followed by 1.2 micrograms/kg daily, usually 75–90 micrograms; use the lower end or a modified plan when cardiac risk is high.
  • Provide ventilatory support early when respiratory drive is inadequate; normal oxygen saturation does not exclude dangerous carbon-dioxide retention.
  • Warm passively and gradually, correct sodium and glucose cautiously, treat infection empirically when suspected, and avoid rapid shifts that add neurological or circulatory injury.
  • Continuous cardiac, temperature, fluid and biochemical monitoring is essential because arrhythmia, ischaemia and treatment-related instability can emerge during recovery.

Key red flags

Neurological deterioration

Lethargy, slowed responses, confusion, psychosis, seizures, stupor or coma may occur. A fall in consciousness alongside hypothermia or bradycardia is particularly concerning and mandates airway assessment.

Respiratory failure

Slow shallow breathing, upper-airway oedema, obesity, effusions or reduced respiratory drive can produce hypoxia and hypercapnia. Obtain a blood gas and involve anaesthesia early when ventilation is failing.

Cardiovascular compromise

Bradycardia, low cardiac output, hypotension, conduction delay, pericardial effusion and occasionally heart failure or ischaemia create a fragile circulation that can be worsened by aggressive warming or hormone loading.

Metabolic signature

Hyponatraemia, hypoglycaemia, raised creatine kinase, renal impairment and respiratory acidosis support severe systemic disease but are not specific; correction speed and underlying mechanism must be assessed.

Hidden precipitant

Pneumonia or urinary infection may lack fever in a hypothermic patient; review myocardial ischaemia, stroke, trauma, drug exposure and omitted hormone even if one trigger initially seems obvious.

Investigation priorities

01
Bedside ABCDE observations and core temperatureFirst step

Identify immediate ventilatory, circulatory and thermoregulatory failure.

Management branches

First hourResuscitate and recruit specialists

Severe hypothyroid decompensation is clinically suspected.

  1. Call critical care, endocrinology and senior acute support; perform ABCDE with continuous ECG, core temperature, glucose and urine-output monitoring.
  2. Secure oxygenation and ventilation, obtain blood gas and prepare intubation when consciousness or carbon-dioxide clearance is inadequate.
  3. Take thyroid tests, cortisol, cultures and metabolic bloods rapidly, but begin steroid, supportive and infection treatment without waiting for results.

Key medicines

Hydrocortisone emergency coverCommon UK emergency practice begins with 100 mg intravenously or intramuscularly, followed by the current adrenal-crisis schedule; verify ongoing dose and route with the BNF and local protocol.Draw cortisol first only if immediate treatment is not delayed. Monitor glucose, sodium, potassium, fluid balance and infection, then reassess need with endocrinology after recovery.
Levothyroxine in myxoedema comaAfter glucocorticoid protection, give an adult intravenous loading dose of 200–500 micrograms, never exceeding 500 micrograms, then parenteral levothyroxine 1.2 micrograms/kg daily, usually 75–90 micrograms, with a lower-end or modified specialist plan for major cardiac risk.Parenteral therapy and large loading doses can provoke ischaemia or arrhythmia. Give only after steroid protection, verify formulation, and follow serial clinical and biochemical response.
Open full textbook →Answer 2 questions
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BNF hypothyroidism emergency treatment summaryUK prescribing and emergency replacement context.
  • BNF liothyronine sodium monographCurrent specialist parenteral prescribing information and cautions.
  • BNF levothyroxine sodium monographCurrent formulation, route, interaction and cardiac-risk details.
  • Society for Endocrinology clinical guidance hubCheck the live endocrine-emergency guidance and local adoption at point of care.
  • Society for Endocrinology adrenal crisis guidanceStress-dose glucocorticoid and emergency supportive principles.
  • Levothyroxine SERB injection SmPCLicensed myxoedema-coma indication, adult 200–500-microgram loading range, 500-microgram maximum, weight-based maintenance and cardiovascular cautions.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftAwaiting review
Clinical state
JurisdictionUnited Kingdom